Current and Upcoming Studies

This is a research study investigating a potential new medication for type 2 weight management.

This study is investigating a potential new treatment that aims to lower hypertension (blood pressure that is too high) when used alongside standard treatments.

Canopy Clinical has launched a suite of weight-management related studies. Register your interest in participating today.

Diabetic foot ulcers (DFUs) are a serious and common complication of diabetes, affecting millions of people worldwide. This study is investigating a potential topical treatment called CYWC628. The treatment aims to support wound healing by promoting tissue regeneration, reducing inflammation, and improving blood flow to the affected area.

This clinical research study is investigating a potential tropical treatment for mild to moderate toenail fungal infections (onychomycosis). Onychomycosis is a common chronic condition that causes thickening, discoloration, and damage to the toenails.

This study is investigating the effect of an investigational oral medication, which is designed to reduce pain and swelling during an acute gout flare.

Osteoarthritis (OA) is a chronic joint condition that affects millions of people worldwide, particularly older adults. This study is investigating a potential new treatment to help reduce knee pain and improve joint function in people living with OA.

This is a research study investigating a potential new treatment for people with moderate to severe asthma.

Migraine headaches are a common, debilitating medical condition, impacting more than 4.9 million Australians. This study is researching an investigational treatment for people living with migraine headaches who are between the ages of 18 and 65.

This is a research study investigating a potential new medication for Coeliac disease.

This is a research study investigating a potential new treatment for atherosclerosis, a chronic heart disease.

This research study is investigating a new potential treatment for Venous Leg Ulcers (VLUs), a clear gel containing an experimental drug that is applied directly to the VLU; compared to a control placebo gel treatment.

This study is investigating the use of a new medication that is a combination of two previously approved treatments for hypertension to target the CNS physiological stress system for patients with panic disorder.